Suppr超能文献

一步柱上纯化及针对肿瘤坏死因子α的单链可变片段(scFv)抗体复性

One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.

作者信息

Liu Mengyuan, Wang Xiangbin, Yin Changcheng, Zhang Zhong, Lin Qing, Zhen Yongsu, Huang Hualiang

机构信息

The Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Science, 100050 Beijing, People's Republic of China.

出版信息

Biotechnol Appl Biochem. 2006 Mar;43(Pt 3):137-45. doi: 10.1042/BA20050194.

Abstract

Single-chain variable fragment (scFv) is a low-molecular-mass recombinant antibody and is usually expressed as inclusion bodies in Escherichia coli. Highly efficient purification and refolding methods are required to provide enough active proteins for therapeutic or diagnostic use. In the present study, an anti-TNFalpha (tumour necrosis factor alpha) scFv (TNF-scFv) was constructed and expressed in E. coli BL21(DE3) star as inclusion bodies, and a convenient procedure of one-step on-column purification and refolding was provided for it. Briefly, denatured TNF-scFv was firstly captured by immobilized metal (Ni) affinity chromatography, and then non-denaturing detergent (Triton X-100)-containing and beta-cyclodextrin-containing solutions were loaded in turn on to the column to perform 'artificial chaperone-assisted refolding' after removing impurities. More than 77% of denatured TNF-scFv protein was refolded successfully with a purity of more than 95%. Activity assays showed that refolded TNF-scFv could bind to rhTNFalpha (recombinant human TNFalpha) specifically with high affinity. It could inhibit rhTNFalpha from binding to TNF receptors and neutralize the cytolytic activity of rhTNFalpha against L929 cells effectively. A conclusion was obtained that this refolding method is time-saving and suitable for industrial production. It may also be applicable to other scFvs or other recombinant proteins.

摘要

单链可变片段(scFv)是一种低分子量重组抗体,通常在大肠杆菌中以包涵体形式表达。需要高效的纯化和重折叠方法来提供足够的活性蛋白用于治疗或诊断用途。在本研究中,构建了一种抗TNFα(肿瘤坏死因子α)scFv(TNF-scFv),并在大肠杆菌BL21(DE3) star中作为包涵体表达,同时为其提供了一种便捷的一步柱上纯化和重折叠方法。简而言之,首先通过固定化金属(镍)亲和色谱捕获变性的TNF-scFv,然后依次将含有非变性去污剂(Triton X-100)和β-环糊精的溶液加载到柱上,在去除杂质后进行“人工伴侣辅助重折叠”。超过77%的变性TNF-scFv蛋白成功重折叠,纯度超过95%。活性分析表明,重折叠的TNF-scFv能够以高亲和力特异性结合重组人TNFα(rhTNFα)。它可以抑制rhTNFα与TNF受体结合,并有效中和rhTNFα对L929细胞的细胞溶解活性。得出的结论是,这种重折叠方法省时且适用于工业生产。它也可能适用于其他scFv或其他重组蛋白。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验